Inhibition of choroidal neovascularization by lentivirusmediated PEDF gene transfer in rats

• 作者: Bin Mo Chang-Li Yue Lu Liu Wu Liu Ya-Jie Yu Yan-Kun Yue
• 来源期刊: 国际眼科杂志：英文版
• 学科: 医学
• 关键词: pigment epithelium-derived FACTOR choroidal NEOVASCULARIZATION LENTIVIRUS vascular endothelial growth FACTOR FLK-1
• 年，卷（期）: 2016,（8）
• 页码范围: 1112-1120
• 页数: 0页
• 分类号: R773.4

摘要

AIM: To evaluate the effects of lentivirus-mediated pigment epithelium-derived factor(PEDF) gene transfer performed in treatment of rats with established choroidal neovascularization(CNV), and investigates the mechanism by which PEDF inhibits CNV in rats.METHODS: Brown Norway(BN) rats(n =204) were induced by exposure to a laser, and then randomly assigned to 3 groups: no treatment; treatments with intravitreal injection of lentivirus-PEDF-green fluorescent protein(GFP) or lentivirus-control GFP(free fluorescent protein). Following induction and treatment,the CNV tissue was assessed for form, size and vessel leakage by fluorescein fundus angiography(FFA), optical coherence tomography(OCT), histopathology, and examination of choroidal flat mounts. VEGF, Flk-1, and PEDF expression were evaluated by real-time polymerase chain reaction(PCR) and Western blot.RESULTS: A stable laser-induced rat model of CNV was successfully established, and used to demonstrate lentivirus-mediated PEDG gene transfer by intravitreal injection. Expression of green fluorescence labelled PEDF was observed in the retina up to 28 d after injection. An intravitreal injection of lentivirus-PEDF-GFP at 7d led to a significant reduction in the size,thickness and area of CNV showed by FFA, OCT and choroidal flat mounts. PEDF was up-regulated while VEGF and Flk-1 were down-regulated in the lentivirus-PEDF-GFP group. The differences in VEGF and Flk-1 expression in the control and lentivirus-PEDF groups at 7, 14, 21 and 28 d after laser induction were all statistically significant. CONCLUSION: Lentivirus-mediated PEDF gene transfer is effective for use in treatment of laser-induced CNV, and PEDF exerts its therapeutic effects by inhibiting expression of VEGF and Flk-1.